Published in J Neurosci on October 01, 2002
Corticostriatal connectivity and its role in disease. Nat Rev Neurosci (2013) 2.34
The subthalamic nucleus is one of multiple innervation sites for long-range corticofugal axons: a single-axon tracing study in the rat. J Neurosci (2012) 1.38
Understanding decision-making deficits in neurological conditions: insights from models of natural action selection. Philos Trans R Soc Lond B Biol Sci (2007) 1.35
Primary motor cortex of the parkinsonian monkey: differential effects on the spontaneous activity of pyramidal tract-type neurons. Cereb Cortex (2010) 1.25
Phase relationships support a role for coordinated activity in the indirect pathway in organizing slow oscillations in basal ganglia output after loss of dopamine. Neuroscience (2006) 1.19
Basal ganglia activity patterns in parkinsonism and computational modeling of their downstream effects. Eur J Neurosci (2012) 0.97
Reduced cortical innervation of the subthalamic nucleus in MPTP-treated parkinsonian monkeys. Brain (2015) 0.76
Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum Mol Genet (2003) 3.51
The cerebellum communicates with the basal ganglia. Nat Neurosci (2005) 3.27
Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest (2008) 2.91
Missing pieces in the Parkinson's disease puzzle. Nat Med (2010) 2.90
Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat Neurosci (2004) 2.84
JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A (2004) 2.05
Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease. Proc Natl Acad Sci U S A (2008) 1.93
The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease. Proc Natl Acad Sci U S A (2007) 1.78
Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors. Proc Natl Acad Sci U S A (2007) 1.71
Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. J Clin Invest (2010) 1.64
Localization of stimulating electrodes in patients with Parkinson disease by using a three-dimensional atlas-magnetic resonance imaging coregistration method. J Neurosurg (2003) 1.35
Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure. Glia (2004) 1.34
Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease. J Neurochem (2003) 1.32
Thalamic neuronal activity in dopamine-depleted primates: evidence for a loss of functional segregation within basal ganglia circuits. J Neurosci (2005) 1.30
Behavioural disorders induced by external globus pallidus dysfunction in primates: I. Behavioural study. Brain (2004) 1.27
The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy. J Neurochem (2005) 1.27
Persistent increase in olfactory type G-protein alpha subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease. J Neurosci (2004) 1.23
Annonacin, a natural mitochondrial complex I inhibitor, causes tau pathology in cultured neurons. J Neurosci (2007) 1.18
Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease. J Neurochem (2003) 1.16
Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats. J Neurochem (2003) 1.15
A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery. Brain (2007) 1.14
Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease. J Neurochem (2002) 1.13
New striatal dopamine neurons in MPTP-treated macaques result from a phenotypic shift and not neurogenesis. Brain (2006) 1.12
Rescue of mesencephalic dopaminergic neurons in culture by low-level stimulation of voltage-gated sodium channels. J Neurosci (2004) 1.10
Protection of midbrain dopaminergic neurons by the end-product of purine metabolism uric acid: potentiation by low-level depolarization. J Neurochem (2009) 1.09
Behavioural disorders induced by external globus pallidus dysfunction in primates II. Anatomical study. Brain (2004) 1.08
Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe. J Neurochem (2004) 1.08
Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism. Proc Natl Acad Sci U S A (2011) 1.07
Inflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter. Exp Neurol (2003) 1.06
Behavioral changes are not directly related to striatal monoamine levels, number of nigral neurons, or dose of parkinsonian toxin MPTP in mice. Neurobiol Dis (2003) 1.05
Normal and pathological gait: what we learn from Parkinson's disease. J Neurol Neurosurg Psychiatry (2012) 1.04
Dopaminergic substantia nigra neurons project topographically organized to the subventricular zone and stimulate precursor cell proliferation in aged primates. J Neurosci (2006) 1.04
Behavioral and movement disorders induced by local inhibitory dysfunction in primate striatum. Cereb Cortex (2008) 1.03
Neuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca2+. FASEB J (2011) 1.01
Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism. Brain (2007) 1.01
The phenotypic differentiation of locus ceruleus noradrenergic neurons mediated by brain-derived neurotrophic factor is enhanced by corticotropin releasing factor through the activation of a cAMP-dependent signaling pathway. Mol Pharmacol (2006) 0.99
Role of TNF-alpha receptors in mice intoxicated with the parkinsonian toxin MPTP. Exp Neurol (2002) 0.99
The pallidosubthalamic projection: an anatomical substrate for nonmotor functions of the subthalamic nucleus in primates. Mov Disord (2005) 0.97
Bee venom and its component apamin as neuroprotective agents in a Parkinson disease mouse model. PLoS One (2013) 0.96
High-frequency stimulation of the anterior subthalamic nucleus reduces stereotyped behaviors in primates. J Neurosci (2008) 0.95
Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease. Sci Rep (2013) 0.94
Effect of intrastriatal 6-OHDA lesion on dopaminergic innervation of the rat cortex and globus pallidus. Exp Neurol (2005) 0.93
Three-dimensional cartography of functional territories in the human striatopallidal complex by using calbindin immunoreactivity. J Comp Neurol (2002) 0.93
Behavioral recovery in MPTP-treated monkeys: neurochemical mechanisms studied by intrastriatal microdialysis. J Neurosci (2008) 0.93
Cigarette smoke and nicotine protect dopaminergic neurons against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Parkinsonian toxin. Brain Res (2003) 0.92
Flavaglines as potent anticancer and cytoprotective agents. J Med Chem (2012) 0.92
Gait disorders in parkinsonian monkeys with pedunculopontine nucleus lesions: a tale of two systems. J Neurosci (2013) 0.92
Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid. J Neurochem (2008) 0.91
7 Tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson's disease. Mov Disord (2014) 0.89
Proliferation of microglial cells induced by 1-methyl-4-phenylpyridinium in mesencephalic cultures results from an astrocyte-dependent mechanism: role of granulocyte macrophage colony-stimulating factor. J Neurochem (2005) 0.88
Specific needs of dopamine neurons for stimulation in order to survive: implication for Parkinson disease. FASEB J (2013) 0.88
Donepezil induces a cholinergic sprouting in basocortical degeneration. J Neurochem (2007) 0.87
Blood vessels and parkinsonism. Front Biosci (2004) 0.86
Evidence for a dopaminergic innervation of the pedunculopontine nucleus in monkeys, and its drastic reduction after MPTP intoxication. J Neurochem (2009) 0.86
Dysfunction of the subthalamic nucleus induces behavioral and movement disorders in monkeys. Mov Disord (2009) 0.86
The neurotransmitter noradrenaline rescues septal cholinergic neurons in culture from degeneration caused by low-level oxidative stress. Mol Pharmacol (2005) 0.86
Quantitative analysis of dopaminergic loss in relation to functional territories in MPTP-treated monkeys. Eur J Neurosci (2003) 0.86
The iron-binding protein lactoferrin protects vulnerable dopamine neurons from degeneration by preserving mitochondrial calcium homeostasis. Mol Pharmacol (2013) 0.85
Effect of mitochondrial complex I inhibition on Fe-S cluster protein activity. Biochem Biophys Res Commun (2011) 0.83
MRI atrophy of the caudate nucleus and slower walking speed in the elderly. Neuroimage (2012) 0.83
Role of activity-dependent mechanisms in the control of dopaminergic neuron survival. J Neurochem (2007) 0.83
Regional vulnerability of mesencephalic dopaminergic neurons prone to degenerate in Parkinson's disease: a post-mortem study in human control subjects. Neurobiol Dis (2006) 0.82
Frontal non-invasive neurostimulation modulates antisaccade preparation in non-human primates. PLoS One (2012) 0.82
Distribution and morphology of nigral axons projecting to the thalamus in primates. J Comp Neurol (2002) 0.82
Heat shock protein 60: an endogenous inducer of dopaminergic cell death in Parkinson disease. J Neuroinflammation (2014) 0.82
Substance P, neurokinins A and B, and synthetic tachykinin peptides protect mesencephalic dopaminergic neurons in culture via an activity-dependent mechanism. Mol Pharmacol (2005) 0.81
Effects of dopamine and serotonin antagonist injections into the striatopallidal complex of asymptomatic MPTP-treated monkeys. Neurobiol Dis (2012) 0.81
A direct prefrontotectal tract against distractibility in the human brain. Ann Neurol (2003) 0.81
Increased expression and redistribution of the antiapoptotic molecule Bcl-xL in Parkinson's disease. Neurobiol Dis (2002) 0.81
Behavioral consequences of bicuculline injection in the subthalamic nucleus and the zona incerta in rat. J Neurosci (2002) 0.81
Towards a primate model of Gilles de la Tourette syndrome: anatomo-behavioural correlation of disorders induced by striatal dysfunction. Cortex (2012) 0.81
Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J Neurochem (2012) 0.81
Disruption of self-organized actions in monkeys with progressive MPTP-induced parkinsonism: II. Effects of reward preference. Eur J Neurosci (2004) 0.80
Quantitative evaluation of the human subventricular zone. Brain (2012) 0.80